MXPA05013703A - Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale. - Google Patents

Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale.

Info

Publication number
MXPA05013703A
MXPA05013703A MXPA05013703A MXPA05013703A MXPA05013703A MX PA05013703 A MXPA05013703 A MX PA05013703A MX PA05013703 A MXPA05013703 A MX PA05013703A MX PA05013703 A MXPA05013703 A MX PA05013703A MX PA05013703 A MXPA05013703 A MX PA05013703A
Authority
MX
Mexico
Prior art keywords
aivlosin
treatment
disease due
brachyspira pilosicoli
ornithobacterium rhinotracheale
Prior art date
Application number
MXPA05013703A
Other languages
English (en)
Spanish (es)
Inventor
Michael Sanders
Original Assignee
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eco Animal Health Ltd filed Critical Eco Animal Health Ltd
Publication of MXPA05013703A publication Critical patent/MXPA05013703A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicinal Preparation (AREA)
MXPA05013703A 2003-07-03 2004-07-05 Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale. MXPA05013703A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0315629.6A GB0315629D0 (en) 2003-07-03 2003-07-03 New uses for antibiotic
PCT/GB2004/002887 WO2005002593A1 (en) 2003-07-03 2004-07-05 Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale

Publications (1)

Publication Number Publication Date
MXPA05013703A true MXPA05013703A (es) 2006-03-08

Family

ID=27741546

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013703A MXPA05013703A (es) 2003-07-03 2004-07-05 Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale.

Country Status (11)

Country Link
US (1) US20060166905A1 (enExample)
EP (1) EP1641469A1 (enExample)
JP (1) JP4823900B2 (enExample)
KR (1) KR20060027799A (enExample)
CN (2) CN101879177B (enExample)
BR (1) BRPI0412288A (enExample)
CA (1) CA2530922A1 (enExample)
GB (1) GB0315629D0 (enExample)
MX (1) MXPA05013703A (enExample)
RU (1) RU2005140156A (enExample)
WO (1) WO2005002593A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006130A1 (en) * 2005-06-16 2007-01-18 Aimleds Corporation Lighting assembly, heat sink, and handrail incorporating a lighting assembly
RU2412710C2 (ru) 2006-07-13 2011-02-27 Эко Энимал Хелс Лимитед Применение тилвалосина в качестве противовирусного агента
FR2909558B1 (fr) * 2006-12-12 2009-04-17 Ceva Sante Animale Sa Procede de fabrication de premelanges medicamenteux
CN106361707B (zh) * 2016-09-30 2019-02-26 广东温氏大华农生物科技有限公司 一种酒石酸泰万菌素颗粒制剂及其制备方法
CN107485604A (zh) * 2017-07-13 2017-12-19 中牧实业股份有限公司黄冈动物药品厂 一种改进的酒石酸泰万菌素可溶性粉及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139088A (en) * 1976-05-15 1977-11-19 Sanraku Inc Antibiotics tyrocin derivatives and their preparation
US4092473A (en) * 1975-08-01 1978-05-30 Sanraku Ocean Co., Ltd. Tylosin derivatives and their manufacturing process
GB0025556D0 (en) * 2000-10-18 2000-12-06 Eco Animal Health Ltd Treatment and prophylaxis of disease and infections of pigs and poultry

Also Published As

Publication number Publication date
WO2005002593A1 (en) 2005-01-13
CN1812796A (zh) 2006-08-02
JP2007516945A (ja) 2007-06-28
US20060166905A1 (en) 2006-07-27
BRPI0412288A (pt) 2006-09-19
GB0315629D0 (en) 2003-08-13
RU2005140156A (ru) 2006-08-27
EP1641469A1 (en) 2006-04-05
CA2530922A1 (en) 2005-01-13
KR20060027799A (ko) 2006-03-28
JP4823900B2 (ja) 2011-11-24
CN1812796B (zh) 2010-12-08
CN101879177A (zh) 2010-11-10
CN101879177B (zh) 2012-10-03

Similar Documents

Publication Publication Date Title
PL377122A1 (pl) Pochodne fenetanoloaminy do leczenia chorób układu oddechowego
TW200637522A (en) Skin treatment articles and methods
PT1656346E (pt) Indole 1,2,3,4-tetrassubstituído para o tratamento de doenças respiratórias
MY147247A (en) Organic compounds and their uses
PT1611091E (pt) Cristais estáveis de natamicina em forma de agulha
GB0520687D0 (en) Skin treatment formulations
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
AU2003249356A1 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
EP1636160A4 (en) NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLISM AND SKIN DISEASES
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
PL1670482T5 (pl) Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
UA104714C2 (ru) Выделенный полинуклеотид brachyspira hyodysenteriae, кодирующий полипептид, и его применение
TWI347843B (en) Treatment of bacterial diseases of the respiratory organs
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
MXPA05013703A (es) Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale.
UA96926C2 (ru) Применение sdf-1 для лечения и/или профилактики неврологических заболеваний
EP1697302A4 (en) COMPOUNDS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF BONE INJURIES AND METABOLIC DISORDERS
PL1612210T3 (pl) Nowe analogi nitrobenzylotioinozyny
WO2008028888A3 (en) Use of cripto-1 or cripto-3 for the treatment of skeletal muscle wasting
EP1498145A4 (en) LURE FOR THE TREATMENT AND / OR PREVENTION OF ALLERGIC DISEASE ASSOCIATED WITH CYTOKINE TH2, MUTANT PROTEIN GATA3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases

Legal Events

Date Code Title Description
FG Grant or registration